Literature DB >> 31377233

"Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.

Sang-Won Yoo1, Yoon-Sang Oh1, Eo-Jin Hwang2, Dong-Woo Ryu1, Kwang-Soo Lee1, Chul Hyoung Lyoo3, Joong-Seok Kim4.   

Abstract

Depression can occur before the onset of motor symptoms in Parkinson's disease (PD) patients. The pathophysiology of depression in PD involves various brain regions and relevant functional circuits. This study investigated whether there exist distinctive patterns of presynaptic monoamine transporter densities in the basal ganglia depending on the degree of depression in patients with PD. A total of 123 early and drug-naïve PD patients were enrolled. Their affective status was evaluated by the Montgomery-Asberg Depression Rating Scale (MADRS), and subjects were subgrouped into one of the following three groups according to their MADRS scores: no depression, mild depression, and moderate-to-severe depression. All patients underwent positron emission tomography (PET) using 18F-N-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane. The PET images were normalized, and differences in the regional standardized uptake value ratios (SUVRs) for each side of the caudate, putamen, globus pallidus, thalamus, and ventral striatum were analyzed and compared between the three groups. A trend analysis was performed across the groups to discern any associations between SUVR values of the basal ganglia and depression severity. The SUVR values of the caudate, anterior caudate nuclei, and ventral striatum declined as MADRS increased. The SUVR values of the striatum showed an inverse dose-dependent trend of antero- and ventroposterior gradient across the groups. This result indirectly revealed the involvement of the associative and limbic circuitry of the brain that are modulated by monoamines in early PD with depression. This might suggest an in vivo causal relationship between the ventral striatum, caudate and depression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caudate; Depression; Dopamine transporter uptake; Montgomery–Asberg depression rating scale; Parkinson's disease; Ventral striatum

Year:  2019        PMID: 31377233     DOI: 10.1016/j.nbd.2019.104563

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

Review 1.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

Review 2.  The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.

Authors:  Ke-Ru Li; An-Guo Wu; Yong Tang; Xiao-Peng He; Chong-Lin Yu; Jian-Ming Wu; Guang-Qiang Hu; Lu Yu
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

3.  Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson's disease without dementia.

Authors:  Yoon-Sang Oh; Jean Hee Kim; Sang-Won Yoo; Eo-Jin Hwang; Chul Hyoung Lyoo; Kwang-Soo Lee; Joong-Seok Kim
Journal:  Neurol Sci       Date:  2020-10-31       Impact factor: 3.307

Review 4.  Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.

Authors:  Giovanni Palermo; Sara Giannoni; Gabriele Bellini; Gabriele Siciliano; Roberto Ceravolo
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

Review 5.  Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior.

Authors:  Gianpaolo Antonio Basile; Salvatore Bertino; Alessia Bramanti; Rosella Ciurleo; Giuseppe Pio Anastasi; Demetrio Milardi; Alberto Cacciola
Journal:  Eur J Histochem       Date:  2021-10-13       Impact factor: 3.188

6.  CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice.

Authors:  Xiaojie Liu; Hao Yu; Bixuan Chen; Vladislav Friedman; Lianwei Mu; Thomas J Kelly; Gonzalo Ruiz-Pérez; Li Zhao; Xiaowen Bai; Cecilia J Hillard; Qing-Song Liu
Journal:  Biomedicines       Date:  2022-07-22

7.  Neuropsychiatric Symptoms in Parkinson's Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden.

Authors:  Hannah von Eichel; Johanne Heine; Florian Wegner; Sophia Rogozinski; Stephanie Stiel; Adrian Groh; Lea Krey; Günter U Höglinger; Martin Klietz
Journal:  Brain Sci       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.